abirateron teva 500 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - abirateron - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg abiraterona u obliku acetata
reseligo 10,8 mg/1 implantat implantat
alvogen pharma d.o.o. - гозерелин - implantat - 10,8 mg/1 implantat - 1 implantat sadrži: 10,8 mg goserelina (12,5 mg goserelin acetata)
reseligo 3,6 mg/1 implantat implantat
alvogen pharma d.o.o. - гозерелин - implantat - 3,6 mg/1 implantat - 1 implantat sadrži: 3,6 mg goserelina (4,1 mg goserelin acetata)
abirateron zentiva 500 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - abirateronacetat - filmom obložena tableta - 500 mg - urbroj: svaka tableta sadrži 500 mg abirateronacetata
reseligo 10,8 mg/1 implantat implantat
zentiva pharma d.o.o. - гозерелин - implantat - 10,8 mg/1 implantat - 1 implantat sadrži: 10,8 mg goserelina (12,5 mg goserelin acetata)
reseligo 3,6 mg/1 implantat implantat
zentiva pharma d.o.o. - гозерелин - implantat - 3,6 mg/1 implantat - 1 implantat sadrži: 3,6 mg goserelina (4,1 mg goserelin acetata)
lynparza
astrazeneca ab - olaparib - neoplazme jajnika - antineoplastična sredstva - jajnika cancerlynparza prikazan kao monoterapija za:podržava liječenje odraslih bolesnika s поздними (figo faze iii i iv) u genima brca1/2-mutirani (зародышевой linije i/ili somatskih) brzorezni epitela jajnika, masterbatch cijevi ili primarni перитонеальный rak, koji u odgovor (potpuno ili djelomično) nakon završetka prve linije na bazi platine kemoterapije. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. lynparza in combination with bevacizumab is indicated for the:maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy in combination with bevacizumab and whose cancer is associated with homologous recombination deficiency (hrd) positive status defined by either a brca1/2 mutation and/or genomic instability (see section 5. breast cancerlynparza is indicated as:monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline brca1/2-mutations who have her2-negative, high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy (see sections 4. 2 i 5. monotherapy for the treatment of adult patients with germline brca1/2-mutations, who have her2 negative locally advanced or metastatic breast cancer. pacijenti moraju prethodno bile tretirane s антрациклина i таксана u (neo)adjuvantne ili метастатический, ako pacijenti nisu prikladni za tih postupaka (vidi odjeljak 5. pacijenti s receptore hormona (h)-pozitivnog raka dojke treba također razvili ili nakon pre-hormonska terapija, ili se smatraju neprikladnim za endokrine terapije. adenocarcinoma of the pancreaslynparza is indicated as:monotherapy for the maintenance treatment of adult patients with germline brca1/2-mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen. prostate cancerlynparza is indicated as:monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc) and brca1/2-mutations (germline and/or somatic) who have progressed following prior therapy that included a new hormonal agent. in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with mcrpc in whom chemotherapy is not clinically indicated (see section 5.
qlaira 3 mg/1 tableta+ 2 mg/1 tableta+ 2 mg/1 tableta+ 2 mg/1 tableta+ 3 mg/1 tableta+ 1 mg/1 tableta film tableta
bayer d.o.o. sarajevo - диеногест estradiol - film tableta - 3 mg/1 tableta+ 2 mg/1 tableta+ 2 mg/1 tableta+ 2 mg/1 tableta+ 3 mg/1 tableta+ 1 mg/1 tableta - tamnožuta tableta sa 3 mg estradiol valerata; srednjecrvena tableta sa 2 mg estradiol valerata i 2 mg dienogesta; svijetložuta tableta sa 2 mg estradiolvalerata i 3 mg dienogesta; tamnocrvena tableta sa 1 mg estradiol valerata; bijela tableta ne sadrži aktivnu supstancu
lectrum 3.75 mg/1 bočica prašak i rastvarač za suspenziju za injekciju s produženim oslobađanjem
farmalogist allbix d.o.o. bijeljina - лейпрорелин - prašak i rastvarač za suspenziju za injekciju s produženim oslobađanjem - 3.75 mg/1 bočica - jedna bočica sadrži 3,75 leuprorelin acetata
lectrum 11.25 mg/1 bočica prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem
farmalogist allbix d.o.o. bijeljina - лейпрорелин - prašak i rastvarač za suspenziju za injekciju sa produženim oslobađanjem - 11.25 mg/1 bočica - jedna bočica sadrži 11,25 mg leuprorelin acetata